Description
22,44,000 equity shares of DIPNA PHARMACHEM LIMITED issued on preferential basis pursuant to warrant conversion listed with effect from January 20, 2026.
Summary
BSE has listed 22,44,000 new equity shares of DIPNA PHARMACHEM LIMITED (Scrip Code: 543594) with effect from January 20, 2026. These shares were issued to Non-Promoters on a preferential basis pursuant to conversion of warrants at an issue price of Rs. 13.05 per share. The shares are subject to a lock-in period until July 30, 2026.
Key Points
- 22,44,000 equity shares of Rs. 10/- each issued at a premium of Rs. 3.05/-
- Issued to Non-Promoters on preferential basis through warrant conversion
- Date of allotment: November 29, 2025
- Issue price: Rs. 13.05 per share
- Distinctive numbers: 24045251 to 26289250
- ISIN: INE0MC401013
- Shares rank pari-passu with existing equity shares
- Trading permitted from January 20, 2026
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
- Trading members are informed to note the listing of these new securities
- Lock-in provisions must be observed for the allotted shares
Important Dates
- Date of Allotment: November 29, 2025
- Listing Date: January 20, 2026
- Lock-in Period Ends: July 30, 2026
Impact Assessment
This is a routine corporate action with minimal market impact. The listing of 22.44 lakh shares from warrant conversion represents a capital raising exercise for DIPNA PHARMACHEM LIMITED. The lock-in period until July 30, 2026 ensures these shares cannot be traded immediately, limiting short-term supply pressure. Impact is limited to shareholders and investors of this specific company.
Impact Justification
Routine listing of preferential allotment shares from warrant conversion for a single company with no broader market implications